Table 8

Basivertebral nerve ablation arm: 12-month quality of life results

Quality of life measurementsBasivertebral nerve ablation arm(n=66)P value
Baseline SF-36 (PCS)
Mean, SD (Range)32.1, 6.8 (18.4–46.9)
9 Month SF-36 (PCS)n=60*
Mean, SD (Range)46.8, 9.5 (25.8–60.8)
Mean Change from Baseline, SD14.5, 9.5<0.001†
12 Month SF-36 (PCS)61*
Mean, SD (Range)47.0, 9.9 (25.5–62.2)
Mean Change from Baseline, SD14.9, 10.2<0.001†
Baseline SF-36 (MCS)
Mean, SD (Range)53.4, 9.5 (22.2–69.8)
9 Month SF-36 (MCS)n=60*
Mean, SD (Range)54.1, 8.6 (21.1–64.8)
Mean Change from Baseline, SD0.7, 7.50.48b
12 Month SF-36 (MCS)n=61*
Mean, SD (Range)54.4, 7.6 (26.6–63.5)
Mean Change from Baseline, SD0.8, 8.00.42†
Baseline EQ-5D-5L
Mean, SD (Range)0.61, 0.13 (0.27–0.83)
9 Month EQ-5D-5Ln=60*
Mean, SD (Range)0.81, 0.16 (0.42–1.00)
Mean Change from Baseline, SD0.19, 0.18<0.001†
12 Month EQ-5D-5Ln=61*
Mean, SD (Range)0.81, 0.16 (0.35–1.00)
Mean Change from Baseline, SD0.19, 0.19<0.001†
  • Significant differences were observed for the Physical Component Summary but not the Mental Component Summary in the basivertebral nerve ablation treatment arm at 9 and 12 months post procedure compared with baseline.

  • *As observed. No imputations for missing values.

  • †P value from a paired t-test (baseline to 9 and 12 months) for the BNV ablation arm.

  • EQ-5D-5L, EuroQual Group 5 Dimension 5-Level Quality of Life; MCS, Mental Component Summary; PCS, Physical Component Summary; QOL, quality of life; SF, Short Form.